期刊文献+

克拉霉素、多西环素对雌性BALB/c小鼠下生殖道解脲脲原体及其生物膜的影响 被引量:4

Clarithromycin,Doxycycline,and their Combination Therapy for Ureaplasma Urealyticum and Its Biofilm in the Lower Genital Tract of Female BALB / c Mice
下载PDF
导出
摘要 目的探讨克拉霉素、多西环素对雌性BALB/c小鼠下生殖道解脲脲原体标准株血清4型(UU4)及其生物膜的清除作用。方法构建UU4感染BALB/c小鼠下生殖道生物膜动物模型7d后,将小鼠分为空白组、感染组、克拉霉素组、多西环素组及两者联合用药组,除空白组、感染组小鼠外,分别用上述药物治疗7d和14d,并于治疗结束时及治疗结束后10d时取宫颈组织行扫描电镜(SEM)和荧光显微镜等检查。结果 SEM下克拉霉素、多西环素及两者联合治疗7d后小鼠宫颈仍可见游离的UU及其生物膜,治疗14d后无游离的UU,但生物膜结构仍然存在。结论 UU4形成的生物膜结构不能被常规剂量的克拉霉素和多西环素清除。 Objective To study the role of Clarithromycin and Doxycycline against Ureaplasma urealytieum serovar4 and its biofilm in the lower genital tract of female BALB/c mice. Methods Seven days after establishing the BALB/c murine model of female lower genital tract with Ureaplasma urealyticum serovar4, mice were divided into 5 groups, that are blank control group, U. urealyticum infection group, clarithromycin treatment group, dox- ycycline treatment group and combination treatment group. The mice were treated by Clarithromyein, Doxycyc- line and clarithromycin pius doxycycline for 7 or 14 days except the first two groups. In the second and tenth day after treatment, the cervical tissues were collected and then examined through scanning electron microscope (SEM) and fluorescence microscope. Results Observed through SEM after 7 days' therapy of Clarithromy- cin, Doxycycline and their combination therapy, bacteria and biofilms were still adhering to the cervical muco- sa. After 14 days ,there were still biofilms on the cervical tissues but bacteria could not be observed anymore. Conclusion The biofilms formed by Ureaplasma urealyticum serovar4 could not be eliminated by regular do- ses of Clarithromycin and Doxycycline.
出处 《中国皮肤性病学杂志》 CAS CSCD 北大核心 2015年第2期129-132,147,共5页 The Chinese Journal of Dermatovenereology
关键词 解脲脲原体 生物膜 克拉霉素 多西环素 Ureaplasma urealyticum Biofilm Clarithromycin Doxycycline
  • 相关文献

参考文献14

  • 1Robertson JA,Stemke GW,Davis JJ, et al. Proposal of Ureaplasma par- vum sp. nov. and emended description of Ureaplasma urealyticum (Shepard et al. 1974) Robertson et al. 2001 [ J ]. lnt J Syst Ewl Miero- bio1,2002,52 ( Pt 2 ) :587-597.
  • 2刘毅,陆春,朱国兴,冯佩英.性伴双方泌尿生殖道解脲脲原体感染一致性的临床研究[J].中国麻风皮肤病杂志,2007,23(4):321-322. 被引量:2
  • 3李纪兵,陆春,赖维,罗锐军,马寒,朱国兴,冯佩英,卢荣标,陈智睿.BALB/c小鼠下生殖道解脲脲原体感染动物模型体内生物膜的形成[J].中国皮肤性病学杂志,2013,27(11):1105-1109. 被引量:3
  • 4Tagliabue C, Techasaensiri C, Tortes JP, et al. Efficacy of increasing dosages of clarithromycin for treatment of experimental Mycoplasnm pneumoniae pneumonia [ J ]. J Antimicrob Chemother, 2011,66 ( 10 ) : 2323 -2329.
  • 5Parsek MR, Singh PK. Bacterial biofihns: an emerging link to disease pathogenesis [ J ]. Annu Rev Mierobiol, 2003,57 : 677-701.
  • 6Seneviratne C J, Zhang CF, Samaranayake LP. Dental plaque biofilm in oral health and disease [ J ]. Chin J Dent Res,2011,14 (2) :87-94.
  • 7Cemohorska L. Antibiotic resistance and biofilm formation in Staphylo- coccus aureus strains isolated from urine [ J ]. Klin Mikrobiol Infekc Lek,2010,16(6) :196-198.
  • 8Bosio S, Leekha S, Gamb SI, et al. Mycobacterium fortuitum prosthetic valve endocarditis : a case for the pathogenetic role of biofilms[ J]. Card- iovasc Patho1,2012,21 (4) :361-364.
  • 9Thornton RB, Rigby PJ, Wiertsema SP, et al. Multi-species bacterial biofilm and intracellular infection in otitis media [ J ]. BMC Pediatr, 2011,11:94.
  • 10Singh S, Katiyar R, Kaistha SD. High oxacillin, vancomycin and fluoro- quinolone resistance amongst biofilm forming Staphylococcus anreus i- solates from ulcerative keratitis infections [ J ]. Indian J Med Microbiol,2011,29(3) :312-313.

二级参考文献30

  • 1朱国兴,陆春,刘毅,冯佩英.解脲脲原体基因型之间耐药性差异的初步探讨[J].临床皮肤科杂志,2004,33(12):724-726. 被引量:17
  • 2陆春,朱国兴,刘毅,冯佩英.解脲脲原体与黏液脓性宫颈炎相关性的临床研究[J].临床皮肤科杂志,2005,34(3):144-146. 被引量:1
  • 3曹玉濮 叶元康.支原体与支原体疾病[M].北京:人民卫生出版社,2000.121-126.
  • 4Deguchi T,Yoshida T,Miyazawa T,et al.Association of Ureaplasma urealyticum (biover 2) with nongonococcal urethritis.Sex Transm Dis 2004;31(3):192-195.
  • 5Pitcher D, Sillis M, Robertson JA. Simple method for determining biovar and serovar types of Ureaplasma urealyticum clinical isolates using PCRsingle-strand conformation polymorphism analysis [ J ]. J Clin Microbiol, 2001,39(5 ) : 1840 - 1844.
  • 6Blanchard A, Crabb DW, Dybvig K, et al. Rapid detection of tetM in Mycoplasma hominis and Ureaplasma urealyticum by PCR: tetm confers resistance to tetracycline but not necessaily to doxycycline [ J ]. FEMS Microbiol Lett, 1992,95:277 - 282.
  • 7Dosa E, Nagy E, Falk W, et al. Evaluation of the Etest for susceptibility testing of Mycoplasma hominis and Ureaplasma urealyticum [ J ]. Journal of Antimicrobial Chemotherapy, 1999,43 : 575 - 578.
  • 8Kenny GE, Hooton TM, Roberts MC, et al. Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method [ J]. Antimicrob Agents Chemother, 1989,33 ( 1 ) : 103 - 107.
  • 9Ken B, Waites, Donna M, et al. In Vitro Susceptibilities to and Bactericidal Activities of Garenoxacin (BMS -284756 ) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas [ J ]. Antimicrob Agents Chemother,2003,47( 1 ) :161 - 165.
  • 10Ken B,Waites, Donna M,et al. In Vitro Activities of ABT-773 and Other Antimicrobials against Human Mycoplasmas [ J ]. Antimicrob Agents Chemother,2003,47 ( 1 ) : 39 -42.

共引文献14

同被引文献36

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部